About Parabilis Medicines, Inc.

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Employees: 145
Price: $33.30
Previous close: $33.31
Market capitalization: $3.88B
Volume: 1,114,053
P/E ratio: -0.90
52-week low: $24.51
52-week high: $42.49

Additional performance and financial-statement views load in the interactive application.

Market information is provided for research and visualization and is not investment advice.